Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.
Harvanová Ľ, Štulajterová V, Guman T, Ladická M, Hlebašková M, Chudej J, Šimek M, Štecová N, Flochová E, Kubala J, Simančíková I, Drgoňa Ľ, Vranovský A, Wild A, Mistrík M, Bátorová A. Harvanová Ľ, et al. Among authors: wild a. Neoplasma. 2021 May;68(3):626-630. doi: 10.4149/neo_2021_201113N1223. Epub 2021 Feb 11. Neoplasma. 2021. PMID: 33567854
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
Harousseau JL, Martinelli G, Jedrzejczak WW, Brandwein JM, Bordessoule D, Masszi T, Ossenkoppele GJ, Alexeeva JA, Beutel G, Maertens J, Vidriales MB, Dombret H, Thomas X, Burnett AK, Robak T, Khuageva NK, Golenkov AK, Tothova E, Mollgard L, Park YC, Bessems A, De Porre P, Howes AJ; FIGHT-AML-301 Investigators. Harousseau JL, et al. Blood. 2009 Aug 6;114(6):1166-73. doi: 10.1182/blood-2009-01-198093. Epub 2009 May 21. Blood. 2009. PMID: 19470696 Free article. Clinical Trial.
Unraveling root and rhizosphere traits in temperate maize landraces and modern cultivars: Implications for soil resource acquisition and drought adaptation.
Wild AJ, Steiner FA, Kiene M, Tyborski N, Tung SY, Koehler T, Carminati A, Eder B, Groth J, Vahl WK, Wolfrum S, Lueders T, Laforsch C, Mueller CW, Vidal A, Pausch J. Wild AJ, et al. Plant Cell Environ. 2024 Mar 22. doi: 10.1111/pce.14898. Online ahead of print. Plant Cell Environ. 2024. PMID: 38515431
Controlled experiment finds no detectable citation bump from Twitter promotion.
Branch TA, Cȏté IM, David SR, Drew JA, LaRue M, Márquez MC, Parsons ECM, Rabaiotti D, Shiffman D, Steen DA, Wild AL. Branch TA, et al. Among authors: wild al. PLoS One. 2024 Mar 20;19(3):e0292201. doi: 10.1371/journal.pone.0292201. eCollection 2024. PLoS One. 2024. PMID: 38507397 Free PMC article.
Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, Sinner P, Strack A, Mühl-Zürbes P, Ramadan N, Kunz M, Krönke G, Stich L, Steinkasserer A, Royzman D. Peckert-Maier K, et al. Among authors: wild ab. Front Immunol. 2023 Dec 14;14:1293828. doi: 10.3389/fimmu.2023.1293828. eCollection 2023. Front Immunol. 2023. PMID: 38162675 Free PMC article.
403 results